Table 2.

Top30 Significant HyperMethylated DMRs in CR-HCC Tumor Tissues Compared with Adjacent Non-Tumor Tissues

Chrom	No.CG	Meth.CR-HCC	Meth.APTs	Meth.Diff	Meth.p	Direction	Gene_Name
Chr13	6	0.63922	0.412935	0.226284	2.20E-113	Hyper
Chr13	6	0.63922	0.412935	0.226284	2.20E-113	Hyper	LINC00398
Chr17	9	0.341825	0.18653	0.155295	6.46E-90	Hyper	HOXB-AS3
Chr17	9	0.341825	0.18653	0.155295	6.46E-90	Hyper	HOXB6
Chr17	9	0.341825	0.18653	0.155295	6.46E-90	Hyper	HOXB3
Chr11	7	0.495095	0.351013	0.144788	1.13E-64	Hyper
Chr11	7	0.495095	0.351013	0.144788	1.13E-64	Hyper	ORAOV1
Chr11	7	0.495095	0.351013	0.144788	1.13E-64	Hyper
Chr19	6	0.210449	0.104174	0.106275	2.21E-47	Hyper
Chr19	6	0.210449	0.104174	0.106275	2.21E-47	Hyper
Chr19	6	0.210449	0.104174	0.106275	2.21E-47	Hyper
Chr19	6	0.210449	0.104174	0.106275	2.21E-47	Hyper	ICAM5
Chr19	6	0.210449	0.104174	0.106275	2.21E-47	Hyper
Chr1	8	0.711672	0.49796	0.213712	1.20E-41	Hyper
Chr1	8	0.711672	0.49796	0.213712	1.20E-41	Hyper
Chr1	8	0.711672	0.49796	0.213712	1.20E-41	Hyper
Chr1	8	0.711672	0.49796	0.213712	1.20E-41	Hyper	RP4-794H19.2
Chr1	8	0.711672	0.49796	0.213712	1.20E-41	Hyper	RP11-63G10.3
Chr6	8	0.93899	0.832476	0.104991	1.40E-41	Hyper
Chr6	8	0.93899	0.832476	0.104991	1.40E-41	Hyper	XXbac-BPG308K3.6
Chr6	8	0.93899	0.832476	0.104991	1.40E-41	Hyper	RPL13P
Chr22	6	0.837569	0.539437	0.296242	1.45E-41	Hyper
Chr22	6	0.837569	0.539437	0.296242	1.45E-41	Hyper
Chr22	6	0.837569	0.539437	0.296242	1.45E-41	Hyper	USP18
Chr22	6	0.837569	0.539437	0.296242	1.45E-41	Hyper
Chr1	2	0.572219	0.447216	0.125002	1.58E-40	Hyper
Chr1	2	0.572219	0.447216	0.125002	1.58E-40	Hyper
Chr1	2	0.572219	0.447216	0.125002	1.58E-40	Hyper	MAP3K6
Chr11	14	0.669233	0.534945	0.124809	2.47E-32	Hyper